DK

Donald W. Kufe

DI Dana-Farber Cancer Institute: 50 patents #6 of 1,343Top 1%
AD Arch Development: 13 patents #7 of 350Top 2%
GO Genus Oncology: 13 patents #1 of 2Top 50%
TC The University Of Chicago: 7 patents #61 of 1,377Top 5%
BC Beth Israel Deaconess Medical Center: 2 patents #158 of 672Top 25%
TB Therion Biologics: 1 patents #9 of 14Top 65%
GE Genzyme: 1 patents #498 of 891Top 60%
ME Mercian: 1 patents #54 of 110Top 50%
US US Dept of Health & Human Services: 1 patents #1,144 of 3,044Top 40%
AT Adherex Technologies: 1 patents #12 of 17Top 75%
📍 Wellesley, MA: #12 of 837 inventorsTop 2%
🗺 Massachusetts: #831 of 88,656 inventorsTop 1%
Overall (All Time): #40,497 of 4,157,543Top 1%
59
Patents All Time

Issued Patents All Time

Showing 51–59 of 59 patents

Patent #TitleCo-InventorsDate
5770581 Gene transcription and ionizing radiation: methods and compositions Ralph R. Weichselbaum, Dennis E. Hallahan, Vikas P. Sukhatme 1998-06-23
5676978 Methods of inhibiting undesirable cell growth using a combination of a cyclocreatine compound and a hyperplastic inhibitory agent Beverly A. Teicher, Rima Kaddurah-Daouk 1997-10-14
5641755 Regulation of x-ray mediated gene expression Ralph R. Weichselbaum, Dennis E. Hallahan 1997-06-24
5612318 Control of gene expression by ionizing radiation Ralph R. Weichselbaum, Dennis E. Hallahan, Vikas P. Sukhatme 1997-03-18
5571797 Method of inducing gene expression by ionizing radiation Tsuneya Ohno, Ralph R. Weichselbaum 1996-11-05
5565334 Enhancer sequence for modulating expression in epithelial cells Miyako Abe 1996-10-15
5506343 Antibodies specific for the DF3 carcinoma associated antigen 1996-04-09
5053489 Genetically engineered polypeptides with determinants of the human DF3 breast carcinoma-associated antigen 1991-10-01
4963484 Genetically engineered polypeptides with determinants of the human DF3 breast carcinoma-associated antigen 1990-10-16